The scientist’s investigation covers issues in Virology, Immunology, Virus, Innate immune system and Immune system. His Virology research integrates issues from Tumor necrosis factor alpha, Endothelial activation, Epitope, Antibody and Rash. His work on Pathogenesis, Acquired immune system, Alphavirus and Lymphocyte differentiation as part of general Immunology research is frequently linked to Vascular permeability, bridging the gap between disciplines.
His research in Virus intersects with topics in Heterologous, Monoclonal antibody and Vaccine efficacy. His Innate immune system study integrates concerns from other disciplines, such as Gene expression profiling, Regulation of gene expression, microRNA, Gene and Long non-coding RNA. His work in the fields of Immune system, such as Immunity and Chemokine, intersects with other areas such as Coronavirus.
His primary scientific interests are in Virology, Virus, Immunology, Alphavirus and Immune system. His studies in Chikungunya, Viral replication, Alphavirus infection, Venezuelan equine encephalitis virus and Interferon are all subfields of Virology research. His work on Viral Vaccine as part of general Virus research is frequently linked to Coronavirus, thereby connecting diverse disciplines of science.
As a part of the same scientific family, Mark T. Heise mostly works in the field of Alphavirus, focusing on Replicon and, on occasion, Rift Valley fever. The various areas that he examines in his Immune system study include Gene expression and Monocyte. His Innate immune system study incorporates themes from Viral pathogenesis, Flavivirus, T cell and Cell biology.
His primary areas of study are Virology, Immunology, Immune system, Virus and Severe acute respiratory syndrome coronavirus 2. His work deals with themes such as Epitope and Antibody, which intersect with Virology. His studies in Immunology integrate themes in fields like Host and Outbreak.
His Immunity study in the realm of Immune system connects with subjects such as Hiv patients. Within one scientific family, Mark T. Heise focuses on topics pertaining to RNA under Virus, and may sometimes address concerns connected to DNA and Mutagenesis. His Severe acute respiratory syndrome coronavirus 2 research incorporates elements of Pandemic and Coronavirus.
His scientific interests lie mostly in Immunology, Virus, Alphavirus, Virology and Immune system. His Immunology research is multidisciplinary, incorporating perspectives in Biomarker, Regulation of gene expression, Human genetics and Candidate gene. His research on Virus often connects related topics like Antibody.
The Alphavirus study combines topics in areas such as Attenuated vaccine, Biosafety level and Glycan. Mark T. Heise studies Virology, namely Vaccination. His studies deal with areas such as Host, Immunophenotyping and Outbreak as well as Immune system.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Chikungunya: a re-emerging virus
Felicity J Burt;Micheal S Rolph;Nestor E Rulli;Nestor E Rulli;Suresh Mahalingam.
The Lancet (2012)
NLRX1 is a regulator of mitochondrial antiviral immunity
Chris B. Moore;Daniel T. Bergstralh;Joseph A. Duncan;Yu Lei.
The genome architecture of the collaborative cross mouse genetic reference population
Fuad A. Iraqi;Mustafa Mahajne;Yasser Salaymah;Hani Sandovski.
A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge
Meagan Bolles;Damon Deming;Kristin Michelle Long;Sudhakar Agnihothram.
Journal of Virology (2011)
Severe Acute Respiratory Syndrome Coronavirus ORF6 Antagonizes STAT1 Function by Sequestering Nuclear Import Factors on the Rough Endoplasmic Reticulum/Golgi Membrane
Matthew Frieman;Boyd Yount;Mark Heise;Sarah A. Kopecky-Bromberg.
Journal of Virology (2007)
A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice
Anjeanette Roberts;Damon Deming;Christopher D. Paddock;Aaron Cheng.
PLOS Pathogens (2007)
Genetic analysis of complex traits in the emerging Collaborative Cross
David L. Aylor;William Valdar;Wendy Foulds-Mathes;Ryan J. Buus.
Genome Research (2011)
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
Lisa E. Gralinski;Timothy Patrick Sheahan;Thomas E. Morrison;Vineet D. Menachery;Vineet D. Menachery.
Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance
Angela L. Rasmussen;Atsushi Okumura;Atsushi Okumura;Martin T Ferris;Richard Green.
Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants
Damon Deming;Timothy Sheahan;Mark Heise;Boyd Yount.
PLOS Medicine (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: